一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數據庫列表>858474-14-3

858474-14-3

中文名稱 2-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
英文名稱 2-(4-Methoxyphenyl)-α-2-piperidinyl-4-quinolinemethanol Dihydrochloride
CAS 858474-14-3
分子式 C22H25ClN2O2
分子量 384.9
MOL 文件 858474-14-3.mol
858474-14-3 結構式 858474-14-3 結構式

基本信息

中文別名
化合物 T16352
2-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
英文別名
NSC23925
NSC-23925
2-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
2-(4-Methoxyphenyl)-α-2-piperidinyl-4-quinolinemethanol Dihydrochloride
4-Quinolinemethanol, 2-(4-methoxyphenyl)-α-2-piperidinyl-, hydrochloride
(2-(4-Methoxyphenyl)quinolin-4-yl)(piperidin-2-yl)methanol dihydrochloride
[2-(4-Methoxyphenyl)4-quinolinyl]-(piperidin-2-y)-methanol dihydrochloride

物理化學性質

儲存條件room temp
溶解度H2O:可溶5mg/mL(澄清溶液)
形態(tài)粉末
顏色白色至米色
水溶解性H2O: 5mg/mL (clear solution)
InChI1S/C22H24N2O2.2ClH/c1-26-16-11-9-15(10-12-16)21-14-18(17-6-2-3-7-19(17)24-21)22(25)20-8-4-5-13-23-20;;/h2-3,6-7,9-12,14,20,22-23,25H,4-5,8,13H2,1H3;2*1H
InChIKeyWGWOQHWZXLGPNG-UHFFFAOYSA-N
SMILESCl.Cl.COc1ccc(cc1)-c2cc(C(O)C3CCCCN3)c4ccccc4n2

安全數據

危險性符號(GHS)有毒 (GHS06)
GHS06
警示詞危險
危險性描述H301
危險品標志T
危險類別碼25
安全說明45
危險品運輸編號UN 2811 6.1 / PGIII
WGK Germany3
存儲類別6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects
危險性類別Acute Tox. 3 Oral
2-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE價格(試劑級)
報價日期產品編號產品名稱CAS號包裝價格
2026/06/05HY-196262-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
NSC23925
858474-14-35mg1100元
2026/06/05HY-196262-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
NSC23925
858474-14-310mg1900元
2026/06/05HY-196262-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE
NSC23925
858474-14-325 mg4200元

常見問題列表

生物活性
NSC23925 是一種新型的,有選擇性且有效的 P-糖蛋白 (Pgp) 抑制劑。
靶點

P-glycoprotein

體外研究

NSC23925 is a novel, selective and effective P-glycoprotein (Pgp) inhibitor. SKOV-3 cells with long-term exposure of 1 μM NSC23925 show stable growth in culture medium. NSC23925 specifically inhibits Pgp overexpression to prevent the emergence of paclitaxel resistance during paclitaxel treatment. NSC23925 reverses chemoresistance in a wide variety of tumor types where Multidrug resistance 1 (MDR1) is highly expressed. Maximal reversal of MDR is typically seen in NSC23925 doses between 0.5 and 1 μM. The IC 50 for NSC23925 is 8 μM in SKOV-3/SKOV-3 TR and 25 μM in OVCAR8/OVCAR8 TR cell lines, whereas the mean concentration of NSC23925 required for maximal reversal of resistance in SKOV-3 TR or OVCAR8 TR to cytotoxic drugs is 0.5 μM to 1 μM.

體內研究

Both saline alone and NSC23925 alone treated tumors grow progressively. The usage of NSC23925 in paclitaxel chemotherapy significantly prolongs anticancer efficacy of paclitaxel.

"858474-14-3" 相關產品信息
75-56-9 219859-83-3 107-10-8
红安县| 永定县| 乐昌市| 金溪县| 凤庆县| 桦甸市| 南汇区| 涟源市| 邛崃市| 泗水县| 洞口县| 武冈市| 嘉兴市| 营口市| 巴林左旗| 开原市| 噶尔县| 隆昌县| 贵溪市| 西乌珠穆沁旗| 弥勒县| 天长市| 红桥区| 嘉鱼县| 五河县| 鸡东县| 蒙山县| 东宁县| 永兴县| 高雄市| 茂名市| 安岳县| 建水县| 海林市| 富裕县| 修水县| 璧山县| 安西县| 凌海市| 昌江| 莱阳市|